188 related articles for article (PubMed ID: 36293083)
1. Biological Activity of Different Forms of Oxidized Parathyroid Hormone.
Hasan AA; Hocher CF; Kleuser B; Krämer BK; Hocher B
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293083
[TBL] [Abstract][Full Text] [Related]
2. Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies.
Li M; Hasan AA; Chu C; Hocher JG; Liu Y; Zhang X; Chen X; Yard B; Krämer BK; Hocher B
Pflugers Arch; 2024 Jun; 476(6):889-899. PubMed ID: 38393416
[TBL] [Abstract][Full Text] [Related]
3. Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD.
Zeng S; Querfeld U; Feger M; Haffner D; Hasan AA; Chu C; Slowinski T; Bernd Dschietzig T; Schäfer F; Xiong Y; Zhang B; Rausch S; Horvathova K; Lang F; Karl Krämer B; Föller M; Hocher B
FASEB J; 2020 Nov; 34(11):15269-15281. PubMed ID: 32964520
[TBL] [Abstract][Full Text] [Related]
4. Non-oxidized PTH (n-oxPTH) is associated with graft loss in kidney transplant recipients.
Lu YP; Zeng S; Chu C; Hasan AA; Slowinski T; Yin LH; Krämer BK; Hocher B
Clin Chim Acta; 2020 Sep; 508():92-97. PubMed ID: 32413401
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients.
Zuo J; Hasan AA; Hocher CF; Kalk P; Kleuser B; Krämer BK; Hocher B
Front Endocrinol (Lausanne); 2023; 14():1178166. PubMed ID: 37324252
[TBL] [Abstract][Full Text] [Related]
6. Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients.
Hocher B; Oberthür D; Slowinski T; Querfeld U; Schaefer F; Doyon A; Tepel M; Roth HJ; Grön HJ; Reichetzeder C; Betzel C; Armbruster FP
Kidney Blood Press Res; 2013; 37(4-5):240-51. PubMed ID: 23868100
[TBL] [Abstract][Full Text] [Related]
7. A structural and mechanistic study of the oxidation of methionine residues in hPTH(1-34) via experiments and simulations.
Chu JW; Yin J; Wang DI; Trout BL
Biochemistry; 2004 Nov; 43(44):14139-48. PubMed ID: 15518564
[TBL] [Abstract][Full Text] [Related]
8. Ligand-Dependent Effects of Methionine-8 Oxidation in Parathyroid Hormone Peptide Analogues.
Daley EJ; Khatri A; Dean T; Vilardaga JP; Zaidi SA; Katritch V; Gardella TJ
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33242090
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of recombinant human parathyroid hormone: effect of oxidized position on the biological activity.
Nabuchi Y; Fujiwara E; Ueno K; Kuboniwa H; Asoh Y; Ushio H
Pharm Res; 1995 Dec; 12(12):2049-52. PubMed ID: 8786987
[TBL] [Abstract][Full Text] [Related]
10. Why Current PTH Assays Mislead Clinical Decision Making in Patients with Secondary Hyperparathyroidism.
Hocher B; Yin L
Nephron; 2017; 136(2):137-142. PubMed ID: 28183082
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of parathyroid hormone.
Ursem SR; Vervloet MG; de Jongh RT; Heijboer AC
Clin Chim Acta; 2020 Jul; 506():84-91. PubMed ID: 32178977
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of PTH: in vivo feature or effect of preanalytical conditions?
Ursem SR; Vervloet MG; Hillebrand JJG; de Jongh RT; Heijboer AC
Clin Chem Lab Med; 2018 Jan; 56(2):249-255. PubMed ID: 28809747
[TBL] [Abstract][Full Text] [Related]
13. Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients.
Tepel M; Armbruster FP; Grön HJ; Scholze A; Reichetzeder C; Roth HJ; Hocher B
J Clin Endocrinol Metab; 2013 Dec; 98(12):4744-51. PubMed ID: 24171919
[TBL] [Abstract][Full Text] [Related]
14. Measuring parathyroid hormone (PTH) in patients with oxidative stress--do we need a fourth generation parathyroid hormone assay?
Hocher B; Armbruster FP; Stoeva S; Reichetzeder C; Grön HJ; Lieker I; Khadzhynov D; Slowinski T; Roth HJ
PLoS One; 2012; 7(7):e40242. PubMed ID: 22792251
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?
Drüeke TB; Floege J
Kidney Int; 2021 May; 99(5):1070-1072. PubMed ID: 33892858
[TBL] [Abstract][Full Text] [Related]
16. Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease.
Ursem SR; Heijboer AC; D'Haese PC; Behets GJ; Cavalier E; Vervloet MG; Evenepoel P
Kidney Int; 2021 May; 99(5):1173-1178. PubMed ID: 33422551
[TBL] [Abstract][Full Text] [Related]
17. Effect of methionine oxidation and deletion of amino-terminal residues on the conformation of parathyroid hormone. Circular dichroism studies.
Zull JE; Smith SK; Wiltshire R
J Biol Chem; 1990 Apr; 265(10):5671-6. PubMed ID: 2318832
[TBL] [Abstract][Full Text] [Related]
18. The percentage of non-oxidized PTH concentration remains stable over a period of 1 year in hemodialyzed patients.
Cavalier E; Lukas P; Warling X; Moonen M; Smelten N; Delanaye P
Clin Chim Acta; 2020 Jul; 506():107-109. PubMed ID: 32194038
[TBL] [Abstract][Full Text] [Related]
19. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective oxidation of 1-34 bovine parathyroid hormone on its renal actions in the rabbit.
Pitts TO; Puschett JB; Rose ME; Zull JE
Miner Electrolyte Metab; 1989; 15(5):267-75. PubMed ID: 2554103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
